Preparation of a novel monoclonal antibody specific to DARPP-32

Hybridoma

Volumn 29, Issue 4, 2010, Pages 351-354

  Yang, Jianjun ^a   Li, Mengbin ^a   Hong, Liu ^a   Zhang, Hongwei ^a   Sun, Li ^a   Wang, Weizhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; PHOSPHOPROTEIN DARPP 32;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; UPREGULATION;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTINEOPLASTIC AGENTS; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYBRIDOMAS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; MULTIPLE MYELOMA; RECOMBINANT PROTEINS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 77955866753     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2010.0014     Document Type: Article

References (12)

1. Greengard P: The neurobiology of slow synaptic transmission. Science 2001;294:1024-1030.
2. Wang MS, Pan Y, Liu N, Guo C, Hong L, and Fan D: Overexpression of DARPP-32 in colorectal adenocarcinoma. Inter J Clin Prac 2005;59:58-61.
3. Dupre KB: A potential neuroanatomical dissociation of DARPP-32 in striatal ERK signaling. J Neurosci 2008;28(43): 10783-10785.
4. Lindskog M: Modelling of DARPP-32 regulation to understand intracellular signaling in psychiatric disease. Pharmacopsychiatry 2008;41(Suppl 1):S99-S104.
5. Hong L, Wang J, Zhao Y, Han Z, Zhou X, Guo W, Zhang X, Jin H, Wu K, Ding J, and Fan D: DARPP-32 mediates multidrug resistance of gastric cancer through regulation of P-gp and ZNRD1. Cancer Invest 2007;25(8):699-705. (Pubitemid 350223173)
6. Ji G: A novel monoclonal antibody specific to peptide pdnaelvlltlgqawqg. Hybridoma 2009;28(5):373-376.
7. Han Y, Hong L, Qiu J, Qiao L, Zhong C, Xue T, and Wang M: Preparation and characterization of a novel monoclonal antibody specific to human NOB1 protein. Hybridoma 2008; 27(3):187-190.
8. Li M, Zhang H, Hong L, Jin Y, Gong T, Sun L, Yang J, and Zheng X: Preparation and characterization of a novel monoclonal antibody specific to human CAD protein. Hybridoma 2009;28(2):129-132.
9. Svenningsson P, Nairn AC, and Greengard P: DARPP-32 mediates the actions of multiple drugs of abuse. AAPS J 2005;7(2):E353-360.
10. Le Novère N, Li L, and Girault JA: DARPP-32: molecular integration of phosphorylation potential. Cell Mol Life Sci 2008;65(14):2125-2127.
11. Wang J, Pan YL, Liu N, Guo CC, Hong L, and Fan DM: Expression and significance of DARPP-32 in gastric carcinoma. Zhonghua Bing Li Xue Za Zhi 2004;33(4):350-353.
12. Hong L, Wang J, Han Y, Zhao Y, Gao J, Wang J, Han Y, Zhang X, Yan L, Zhou X, Qiao T, Chen Z, and Fan D: Reversal of multidrug resistance of vincristine-resistant gastric adenocarcinoma cells through up-regulation of DARPP-32. Cell Biol Int 2007;31(9):1010-1015.